We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Walmart is suing the federal government seeking to block civil charges against the company over how it handled prescriptions for opioids that allegedly helped create the opioid epidemic. Read More
The FDA says it won’t take action against wholesale distributors that fail to verify a product identifier or standardized numerical label before distributing saleable returned products. Read More
The COVID-19 pandemic is worsening a pre-existing problem of drug shortages in the U.S., University of Minnesota researchers report in a new analysis. Read More
HHS Secretary Alex Azar denies a report that he and colleagues are plotting the ouster of FDA Commissioner Stephen Hahn over Hahn’s holding fast to stricter, more time-consuming rules for makers of novel COVID-19 vaccines than what the White House wants. Read More
California Governor Gavin Newsom has named an 11-person scientific review panel to verify the safety of any FDA-approved COVID-19 vaccine before it is distributed in the state. Read More
Brazil’s President Jair Bolsonaro announced Wednesday that his government will not purchase a COVID-19 vaccine developed by Beijing-based Sinovac, just one day after the country’s health minister announced it would be placing an order. Read More
The Department of Justice (DOJ) announced an $8.3 billion settlement deal with Purdue Pharma Wednesday to resolve criminal and civil probes into the OxyContin manufacturer, which some critics view as insufficient punishment for the company and its owners, the Sackler family. Read More
Moderna CEO Stéphane Bancel said that the drugmaker’s COVID-19 vaccine candidate could receive an Emergency Use Authorization (EUA) in December if all goes according to plan, with interim data expected out next month. Read More